Advanced Search
Contact | Corporate | Help

Daily news email for June 14, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Batavia Bioservices Opens Laboratory Facility in Greater Boston Area

BioGenes to Develop Specific HCP Assay for Boehringer Ingelheim

ProBioGen Introduces Novel Productivity-Boosting Technology for Therapeutic Protein Production: ...

UBICHEM Group Adds New Large Scale Manufacturing Site

Fundación MEDINA Announces Drug Discovery Collaboration with Cubist Pharmaceuticals, Inc.

 BioSpace
Allergan Inc. Holders Can Proceed With Botox Suit, Judge Rules

Chinese Meditation Prompts Double Positive Punch in Brain White Matter, Texas Tech University Study

Rare Brain Samples Lost in Freezer Failure, Mclean Hospital Reveals

You May Carry Cells From Siblings, Aunts and Uncles, Leiden University Medical Center Study

Polaris, Johnson & Johnson Hatch Idea to Solve Drug R&D Crisis: Work Together Early

BioSpace - Breaking News
LifeSci Advisors, LLC (LSA) Publishes PCA3 Physician Survey Results

Fuse Science Sets New Standard of Transdermal Delivery with Groundbreaking Scientific Results

Generex Biotechnology Corporation Announces OncUView.tv Interviews Featuring the Antigen Express, Inc. AE37 Breast Cancer Vaccine at ASCO 2012

ProBioGen AG Introduces Novel Productivity-Boosting Technology for Therapeutic Protein Production: "Pathway Modulator"

Boston Therapeutics, Inc. Receives $500,000 Equity Investment

Biotech News - Business Wire
Theraclone Sciences Announces Initiation of a Phase 1 Clinical Trial of TCN-202, an Antibody in Development for the Treatment of Human Cytomegalovirus Infection

GenMark Diagnostics Appoints Stephen T. Worland, Ph.D. to Board of Directors

CardiAQ Valve Technologies Reports Cardiovascular Medicine Milestone: First-in-Human Nonsurgical Percutaneous Implantation of a Bioprosthetic Mitral Heart Valve

Advanced Cell Technology to Present at the 2012 Bio International Convention and the Clinical Outlooks for Regenerative Medicine Meeting

Biomax Informatics AG Reaches First Milestone in European Systems and Personalized Medicine Project

 Biotech News - PR Newswire
Grunenthal Presents Strong Pipeline at World's Largest Biotechnology Conference

University Radiology Group Leverages MedInformatix RIS to Achieve Stage 1 Meaningful Use Certification

Cepheid Welcomes UNITAID Commitment To Broaden Access To "Ground-Breaking" Xpert® MTB/RIF

Quest PharmaTech Initiates Phase II Oregovomab Front-Line Chemo-Immunotherapy Clinical Trial in United States

LEO Pharma Initiates Global Search for New Partners
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
California Smoking Tax Vote Outcome Too Close to Call

D Bomb

Astellas and Drais Partner to Launch Virtual Company

Dr. Reddy's and Merck Serono Partner on Biosimilars

Chelsea Execs Take Pay Cuts Amid Troubles

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Riassunto: Il sito web della comunità di pazienti di Quintiles ClinicalResearch.com vince il secondo premio per la sanità sul web (Web Health Award)

Spectra® Caries Detection Aid Named Best of Class by Pride Institute

Quintiles Patient Community ClinicalResearch.com Wins Second Web Health Award

Premier Healthcare Alliance Hospitals Recognized for Reducing Risk, Enhancing Care Quality

The Myelin Repair Foundation Achieves Phase 1 Myelin Repair Clinical Trial

 Clinical Trials - PR Newswire
Paradigm Spine, LLC Announces Landmark Results In Two Recent Publications Based On Its Groundbreaking coflex® IDE Study

PharmAthene Announces Further Progress In Development Of Its SparVax Anthrax Vaccine Program

LifeSci Advisors Publishes PCA3 Physician Survey Results

JDRF and Novo Nordisk Establish R&D Collaboration for Type 1 Diabetes

Innovimmune Biotherapeutics Receives NIH Grant for Development of Novel Automimmune Compounds

 CNN Top Stories
'Teacher of the Year' gets laid off

Move here, get student loans paid

'Sorry' for Bush's head on spike

Comic: My heroes were addicts

Stars attacked on the red carpet
Contract Pharma
Covance UK Sites Receive Eco-Accreditation

EMD Serono Adds to Leadership Team

Boehringer, BioGenes Sign Assay Alliance

Batavia Bioservices Opens U.S. Lab

Almac Introduces QP Program for EU Trials

 FDA Drugs- What's New
Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para observación cardiovascular y uso del medicamento Gilenya (fingolimod) para la esclerosis múltiple

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

Comunicado de la FDA sobre la seguridad de los medicamentos: Informe actualizado sobre la seguridad del medicamento Revlimid (lenalidomida) para el cáncer y el riesgo de nuevos tipos de neoplasias (nuevos tipos de cáncer)

FDA Drug Safety Communication: Revised recommendations for cardiovascular monitoring and use of multiple sclerosis drug Gilenya (fingolimod)

 FDA News - Business Wire
Cannabis Science Appoints Former GlaxoSmithKline Global Director of HIV Research Dorothy Bray, Ph.D., to Scientific Advisory Board Focusing on CS-TATI-1 and Other Emerging Scientific Investigations

Stratatech's StrataGraft® Skin Substitute Granted FDA Orphan Drug Designation

Resumen: Avinger finaliza la inscripción de pacientes en el ensayo clínico mundial CONNECT II en pacientes con enfermedad arterial periférica

New Phase III Data Showed Merck's Investigational Insomnia Medicine Suvorexant Improved Patients' Ability to Fall Asleep and Stay Asleep

OSI Systems Introduces AriaTele Telemetry Transmitter
FDA Press Releases
FDA approves Perjeta for type of late-stage breast cancer

U.S. Marshals seized misbranded drugs in Maine

FDA warns consumers about counterfeit version of Teva's Adderall

FDA issues alert on Reumofan Plus

U.S. Marshals seize unapproved new drug from Crescendo Therapeutics LLC

 FDA Vaccines, Blood and Biologics - What's New
Draft Guidance for Industry: Amendment to Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease and Variant Creutzfeldt-Jakob Disease by Blood and Blood Products

Procleix Ultrio Plus Assay

Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

 FierceBiotech
Bugs living in humans breed biotech startups

J&J, Polaris pact follows series of pharma/VC combos

Economy blamed for jobs shortfall in Bay State's $1B biotech plan

Novo Nordisk centers juvenile diabetes work at new R&D hub

Third Rock funds $40M launch of San Francisco blood disease biotech
FierceBiotech IT
Sequoia-backed startup enters race to make sense of the genome

Stanford spinoff debuts cloud-based R&D software

Pharma rocks many Twitter handles for many reasons

Biogen vet tapped as CIO of Harvard Med School

Novartis predicts drug side effects with computers

 FierceBiotech Research
Stem cell pioneer Shinya Yamanaka splits $1.5M Millennium Technology Prize

Enzyme revealed to be bacteria-killing maestro after all

New drug shows reduces post-stroke brain damage risk in mice

2 HIV drugs prevent breast cancer metastasis in preclinical trials

Anti-rejection drug for bone marrow transplants to hit human trials by 2016

 FiercePharma
Heart docs skeptical of new-generation clotbusters

Is Stada looking at another Russian M&A prospect

Austerity, generics push Lundbeck to cut 600 jobs

Who'll be the biggest drugmaker of them all

Drugmakers warn German pricing is killing innovation
FiercePharma Manufacturing
Loss for CMO Patheon smaller than expected

Pakistan's ex-health director has heart attack under questioning

Bayer files patent on manufacturing process for chewable drug

Fresenius' Kabi unit prospers on competitors' mistakes

Maker of disinfectant systems for dialysis gets FDA warning

FierceVaccines
Vaccine, radiotherapy combo shows hints of prostate cancer efficacy

New HPV vax could treat cancer rather than prevent it

Chlamydia vaccine protects in animal studies

GeoVax: Meeting the HIV vaccine challenge

VaxInnate bird flu shot flies into Phase I

 Health News - BizJournals.com
Johnson & Johnson completes $20B takeover of Synthes

Coastal urgent care practice files for liquidation

Biotech CorMatrix raises $15M for heart failure treatment

Social Madness challengers make their move as 1st round nears end

UNCG wins $4.8M grant
Health News - CNBC
Illinois governor signs bills to save Medicaid "from collapse"

U.S. cancer survivors to rise by a third by 2022: report

Obamacare: A Prescription for Health Care

U.S. targets landlords in fight against medical pot

Insight: Top heart doctors fret over new blood thinners

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
NCATS' Drug Repurposing Program Grows to Eight Pharmas, 58 Compounds

Third Rock Ventures Sets Up New Firm Global Blood Therapeutics with $40.7M

Upsher-Smith Takes Over Proximagen for CNS Disease Therapeutics

Rhythm Scores $25M to Advance Peptide Treatments for Metabolic Disorders

GSK Pays Basilea £146M Up Front for Approved Dermatology Product Toctino
Marketwire - Pharma and Biotech
Vitamin D: The Sunshine Vitamin

Hospital Environmental Surface Contamination Contributes to Transmissible Infection at the Same Level as Direct Patient Contact

Health Enhancement Products, Inc. Names New Chief Science Officer

EPIC Alliance aborde des sujets d'actualit l'intention des femmes ctrophysiologues lors de Cardiostim 2012

Soricimed Biopharma Inc. Attending 2012 BIO International

 MassBio News
CB Richard Ellis N.E. Partners, LP Brings MassBio to Alexandria Real Estate Equities, Inc.'s 300 Technology Square

500 Massachusetts High School Students Spend a Day in Biotech Laboratories

Xenetic Biosciences moves drug development program to Massachusetts following Governor Patrick's Trade Mission to the UK

Breaking: MassBio Applauds House for Passage of PDUFA

Charlton is BioReady

 Medical Pharma - PR Newswire
Destacados científicos jóvenes de Latinoamérica fueron nombrados Becarios Pew en Ciencias Biomédicas 2012

Jovens cientistas notáveis da América Latina são nomeados Bolsistas Pew na Área Biomédica

Spotlight on Russia: Navigating the Barriers

Studies Show Significant Risk Of Skin Cancer In Skin Of Color

Sysmex America Awarded Novation Hematology Contract Agreement
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
European agricultural policy goes down the tubers

The need for innovation in biomanufacturing

Should preclinical studies be registered

Reaching across the table

The gatekeepers of effectiveness

 New York Times- Biotechnology
Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

Craig Venter’s Bugs Might Save the World

Study Backs Continuous Prostate Cancer Treatment

DEALBOOK; Human Genome Sciences Rejects A $2.59 Billion Bid From Glaxo

White House Promotes a Bioeconomy
New York Times- Pharmaceuticals
E-Mails Highlight Extent of Obama’s Deal With Industry on Health Care

When Children Take Drugs to Succeed

Experimental Surgery Targets Stubbornly High Blood Pressure

Genentech Wins Approval For New Breast Cancer Drug

Johnson & Johnson Reserves Funds for Settlement

 OnBioVC
Stemgent, Inc.: Series C $6.3M

Genalyte, Inc.: Series A $11.8M

Relievant Medsystems, Inc.: Series D $30M

ImaginAb, Inc.: Series A $12.5M

BiO2 Medical, Inc.: Series B $13.7M

 Outsourcing-Pharma
Wockhardt targets CMO space for diversification

Overhaul of EU health systems good opportunity for outcomes data providers, says Quintiles

Home visits = regulatory thumbs up ResearchNurses.co thinks so

Home visits are the key to patient retention, says ResearchNurses.co

Kemwell and Boehringer set to finish biologics plant in India
Pharma News - Business Wire
Research and Markets: Japan Pharmaceuticals and Healthcare Report Q3 2012

Samenvatting: ERYTECH sikkelcelanemie behandeling krijgt van European Medicines Agency positief advies

Resumen: El tratamiento para la enfermedad de células falciformes de ERYTECH Pharma recibe opinión positiva para la designación de fármaco huérfano de la Agencia Europea de Medicamentos

Brain & Behavior Research Foundation Scientific Council Member Karl Deisseroth, M.D., Ph.D., Elected to National Academy of Sciences

Cegedim Relationship Management Recognized as a Top Market Leader in Ovum Life Sciences CRM Vendor Report

 Pharma News - PharmiWeb
New Food Company Launches With Aim Of Unjunking The World

Experian Marketing Services' ChoiceScore(SM) now available through preferred provider Adrea Rubin Marketing to life and health insurance vertical

Concentra Opens Advanced Physical Therapy Center

ACPE Announces Support for IOM's CEO Checklist for High Value Health Care

The American Fertility Association's National Spokesperson to Star on TNT's "Dallas"

 Pharma News - PR Newswire
8 Scottish Life Science Companies Descend Upon Boston in Search of Investors and Partners

CytoPharm and Amarillo Biosciences Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients with Mild Fibrosis

Low Awareness of Meningococcal Disease and New Vaccination Recommendations Putting St. Louis Teens at Risk; School Nurses Rally Community in Response

Repealing Brand Drug 'Copay Coupons' Ban Increases Costs by $750 Million for Massachusetts Employers, Unions, and State Employee Health Programs

Runner Embarks On Seven Marathons In Seven Days On Seven Continents
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Romer Labs Launches New Website

SHEL LAB Introduces the Bactrox Chamber

Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

 PRWeb - Biotechnology
The MedZilla.com Employment Report for June 2012 -- Healthcare...

Big Saver: Molderizer Offers 30% Mold Remediation Products Price Cut

SPIE Leaders Welcome New Canadian Consortium Promoting Photonics...

Denver Zoo's Toyota Elephant Passage Exhibit is Certified Platinum

invivodata Opens Registration for PROficiency(TM) Regional Conference...
PRWeb - Pharmaceuticals
Bernstein Liebhard LLP Reports On New Study Concerning Actos Side...

Xybion Wins Frost & Sullivan's Customer Value Enhancement...

Author Judy Johnson Sees Prescription Drug Restrictions Potentially...

FDA To Decide On New Diet Pill while Fen Phen Linked to Severe Adverse...

San Francisco's ACTCM President Lixin Huang to Speak at TEDxWWF...

 Scientific American
Small Comfort: Nanomedicine Able to Penetrate Bodily Defenses

Testing Their Metal: Small Exoplanets Abound in Diverse Stellar Environments

Pollution, Poverty and People of Color: Dirty Soil and Diabetes

Body Count: Taking Stock of all the Bugs That Call Humans Home

Genome Test Slammed for Assessing "Racial Purity"

 Sports - ESPN Basketball
Former Nebraska coach Sadler lands at Kansas

Panel approves rule to enhance court safety

N.D. vote lets school boot Fighting Sioux name

Trial of Oklahoma State's Williams postponed

Temple's Wyatt arrested in prostitution sting
Sports News - ESPN
Michigan DL pleads guilty to destruction charge

Miami, OSU football honored for APR scores

October trial set for 11 FAMU hazing suspects

Auburn shooting suspect appears in court

Accuser: Sandusky called self 'tickle monster'

 Xconomy Life Sciences
Global Blood Therapeutics, Third Rock's First West Coast Startup, Gets $41M

Polaris, J&J Idea to Solve Drug R&D Crisis: Work Together Early

Dendreon Shareholders Vent at Annual Meeting

InDi Unit Looks to Take PET Imaging From Black & White to Technicolor

New InDi Unit Looks to Take PET Imaging From Black & White to Technicolor

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012